I. Cevik et al., SHORT-TERM EFFECT OF DIGITAL RECTAL EXAMINATION ON SERUM PROSTATE-SPECIFIC ANTIGEN LEVELS - A PROSPECTIVE-STUDY, European urology, 29(4), 1996, pp. 403-406
Objective: Prostate-specific antigen (PSA) is widely used as a tumor m
arker in the early detection of prostate cancer. However, its value is
limited by several factors such as not being specific for the cancer
tissue, diurnal variations of the secretion, and changes in the serum
levels observed following rectal manipulations. The effect of digital
rectal examination (DRE) on serum PSA levels is still debatable. Metho
ds: A prospective study is conducted by utilizing the IRMA count (mono
clonal) PSA assay in order to determine the effect of DRE on PSA serum
levels. A total of 50 men (median age 61, range 42-75 years) who pres
ented to our outpatient clinic for the first time with lower urinary t
ract outflow obstruction symptoms were included in this study. Further
evaluation revealed prostate cancer in 5 patients(10%) and benign pro
state hyperplasia in the others. Blood samples were drawn for a PSA as
say from all patients prior to and 30 min and 24 h following DRE (PSA
1-3). Results: The mean PSA values prior to and 30 min and 24 h follow
ing DRE were 4.09 +/- 0.67 range 0.2-19.47) ng/ml, 4.50 +/- 0.63 (0.15
-17.75), and 4.28 +/- 0.68 (0.23-24.12) ng/ml, respectively. The media
n PSA levels for PSA 1, PSA 2, and PSA 3 were 2.49 +/- 4.74, 3.22 +/-
4.48, and 2.62 +/- 4.82 ng/ml, respectively. Although, there was a sta
tistically significant increase in serum PSA levels 30 min after DRE,
the clinical significance of this increase in PSA values with a mean d
ifference of 0.4 ng/ml remains to be clarified. Conclusion: Although t
he effect of DRE on PSA levels does not appear to be clinically signif
icant, in order to prevent any confusion, it may be the best approach
to perform DRE after obtaining serum for PSA analysis.